Direct factory procurement pipelines ensuring analytical consistency, GC-MS verification, and complete regulatory audit support.
Navigating the commercial transition from raw botanical fractions to strictly standardized pharmacopoeial grades in multinational supply frameworks.
The commercial scale of Eucalyptus Oil BP (British Pharmacopoeia) has moved well beyond traditional aromatherapy. High-purity essential oil containing standardized 1,8-cineole (eucalyptol) represents an irreplaceable active pharmaceutical ingredient (API) in respiratory medicine, advanced dental antiseptics, and veterinary antimicrobial solutions worldwide.
Procuring authentic Eucalyptus Oil BP requires verified compliance with chemical markers: eucalyptol content must strictly exceed 70.0% w/w, optical rotation must align within 0° to +10°, and refractions must consistently adhere to 1.458–1.470. Any batch exhibiting traces of synthetic camphene, phellandrene deviation, or foreign adulterants fails standard registration.
Secondary traders frequently aggregate botanical distillates from fragmented sources, exposing formulators to lot-to-lot volatility. Dealing directly with a primary GMP factory like Jiangxi Baicao guarantees continuous vacuum-fractionation rectifications, centralized analytical oversight, and complete batch documentation from raw harvest to final drum packaging.
Every batch dispatched from our Jinggangshan extraction workshop undergoes dual testing against BP / Ph. Eur. physicochemical criteria.
| Analytical Parameter | BP Standard Criteria | Baicao Factory Standard Execution | Primary Test Method |
|---|---|---|---|
| Appearance & Color | Colorless or pale yellow liquid | Colorless, mobile, clear optical clarity | Visual Inspection |
| Odor & Sensory | Aromatic, camphoraceous; pungent and cooling | Conforms fully to native Eucalyptus globulus profile | Organoleptic Panel |
| 1,8-Cineole (Eucalyptol) Assay | ≥ 70.0% (m/m) | Standardized 70.5% – 85.0% (Customizable by fraction) | GC-FID (Capillary Column) |
| Relative Density (20°C / 20°C) | 0.906 to 0.927 | 0.912 to 0.923 | Digital Density Meter |
| Refractive Index (20°C) | 1.458 to 1.470 | 1.460 to 1.467 | Abbe Refractometer (ATC) |
| Optical Rotation (20°C) | 0.0° to +10.0° | +2.0° to +7.5° | Polarimetry |
| Solubility in Ethanol (70% v/v) | Soluble in 5 volumes | Soluble in 3 to 4 volumes without opalescence | Solubility Titration |
| Phellandrene & Impurities | Absence of crystalline nitroso derivatives | Fully negative; heavy hydrocarbons isolated | Monograph Chemical Verification |
Engineered to meet specific dosage matrix parameters across global OTC, veterinary, oral hygiene, and agrochemical formulations.
In pharmaceutical inhalants, steam balms, chest rubs, and lozenges, our oil acts as an expectorant and mucolytic agent. Standardized 1,8-cineole reduces hypersecretion in mucous membranes and relieves bronchial spasms, demanding strict heavy-metal and pesticide-residue compliance under pharmacopoeial limits.
Formulators of mouthwashes and toothpaste utilize Eucalyptus Oil BP to suppress biofilm-forming pathogens like Streptococcus mutans and Porphyromonas gingivalis. The low aldehyde concentration ensures prolonged shelf stability and prevents discoloration in clear gel dentifrices.
As livestock producers phase out synthetic antibiotic growth promoters, our high-grade eucalyptus fractions serve as potent aerosolized treatments for avian viral infections and mycoplasmal respiratory distress, reducing air sac lesions and supporting farm-wide biosecurity.
In high-precision electronics manufacturing and industrial surface cleaning, eucalyptus terpenes deliver non-toxic solvency equivalent to chlorinated solvents. Their elevated Kauri-Butanol value facilitates residue-free degreasing without environmental ozone depletion.
With increasing regulatory bans on synthetic insecticides, eucalyptus oil fractions enriched with terpenes act as potent natural bio-repellents and bio-fungicides. They disrupt insect octopaminergic receptors without inducing soil chemical persistence.
In topical analgesics and sports therapy rubs, eucalyptol modifies stratum corneum intercellular lipid packaging, drastically facilitating the transdermal absorption of active co-compounds such as methyl salicylate and menthol.
Jiangxi Baicao combines domestic agro-botanical clusters with cutting-edge GMP automated continuous distillation systems.
Our strategic location in the Jinggangshan region grants immediate access to China's premier eucalyptus plantation belt. Direct farm-gate partnerships insulate procurement teams from global botanical supply shortages and speculative price spikes, ensuring long-term contractual price stability.
Operating 12 dedicated lines within our 28,600 m² facility, our distillation columns leverage reduced-pressure rectification. This low-temperature processing preserves heat-sensitive terpene fractions while cleanly stripping away undesirable aldehydes that cause olfactory degradation.
With dedicated export documentation teams and proximity to major shipping hubs (Shenzhen, Ningbo, and Shanghai ports), we compress sea-freight dispatch cycles. Standard drum consignments and ISO-tank shipments clear customs rapidly with complete MSDS and dangerous goods paperwork.
Advancing beyond conventional steam distillation through automation, low-carbon extraction, and molecular profiling.
Integrating continuous sensor networks across our fraction towers. Machine learning algorithms dynamically modulate boiler temperature and reflux flow based on real-time infrared spectrophotometric readings, guaranteeing negligible batch variation across all seasons.
Deploying waste biomass energy recirculation. Post-distillation eucalyptus foliage serves as solid biofuel to power factory boilers, while condenser effluent is bio-filtered and recycled. This sustainable circular setup drastically diminishes the corporate carbon footprint.
Formulating advanced micro-emulsions and liposomal-encapsulated eucalyptus powders. These systems resolve volatility issues, minimize volatilization losses during prolonged storage, and unlock new sustained-release opportunities for functional medical devices.
Full documentation packages custom tailored to the rigorous import protocols of Europe, North America, and the Asia-Pacific region.
Complete REACH dossier registration support, full safety data sheet (SDS) compliance aligned with GHS revision 8, and IFRA certificate issuing for downstream fragrance and personal care manufacturers across European territories.
Registered manufacturing site conforming to 21 CFR Part 111 & Part 211 guidance. Full batch manufacturing records (BMR), validated clean-in-place (CIP) procedures, and comprehensive heavy metal/residual solvent profiling per USP guidelines.
Operating under verified ISO 9001:2015 quality management systems. Our production processes are audited and certified for both Kosher and Halal compliance, ensuring smooth customs processing for international distributors.
Direct answers to the critical technical and supply questions asked by pharmaceutical and commercial procurement teams.
We distill exclusively from authenticated fresh foliage of Eucalyptus globulus Labill. The native leaves are screened botanically before extraction to eliminate any atypical cultivars or non-compliant hybrids, securing high eucalyptol content naturally.
Every production lot is subjected to dual testing via GC-MS/MS and ICP-MS in our central QC laboratory. We systematically quantify heavy metals (Pb, Cd, As, Hg) to <0.1 ppm and confirm the complete absence of organochlorine and organophosphorus pesticides below pharmacopoeial thresholds.
We package in fluorinated HDPE drums (25 kg), food-grade epoxy-coated galvanized steel drums (180 kg/200 kg), and 1,000 kg UN-certified IBC tanks. Customized nitrogen-blanketed filling is available for high-tier pharmaceutical API clients.
Yes. Every export shipment is delivered alongside a comprehensive Certificate of Analysis (COA) containing the exact GC-FID / GC-MS chromatogram trace, detailing active percentages for 1,8-cineole, alpha-pinene, limonene, and gamma-terpinene.
For standard BP inventory, dispatch is completed within 3 to 7 working days. Our flexible baseline MOQ starts at 25 kg for pilot qualification, while containerized sea freight orders are manufactured and released within 14 calendar days.
Absolutely. Leveraging 6 vacuum fractionation columns, we can selectively enrich eucalyptol content up to 80%, 85%, or 99% pure pharmaceutical grades, or eliminate specific volatile monoterpenes according to your proprietary formulation specifications.
Explore our factory's complete portfolio of natural plant oils and specialized ingredients, tested and packaged for global industrial supply chains.